Results from Last Month's "The Gold Sheet" Poll
This article was originally published in The Gold Sheet
Last month, we asked you how strong are your quality cultures, based on a five-point scale that Novartis uses. Now the results are.
You may also be interested in...
In its first ASH since acquiring Celgene and with competitors coming, Bristol presented pivotal results for liso-cel (JCAR017) that support a year-end US FDA submission as bb2121 nears a first-half of 2020 filing.
US FDA's Pediatric Experts, Not Review Division, Should Have Final Say On Pediatric Trials, Former Official Says
Former Associate Commissioner Janice Soreth says views of pediatric experts should take precedence over those of division directors regarding pediatric trials.